Publications



Pharmacogenetic study in rectal cancer patients treated with preoperative chemoradiotherapy: polymorphisms in thymidylate synthase, epidermal growth factor receptor, GSTP1, and DNA repair genes.
Int J Radiat Oncol Biol Phys 2011 Dec 11;81(5):1319-27. Epub 2011 May 11.
Department of Medical Oncology, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.

Thymidylate synthase germline polymorphisms in rectal cancer patients treated with neoadjuvant chemoradiotherapy based on 5-fluorouracil.
J Cancer Res Clin Oncol 2010 Nov 18;136(11):1681-9. Epub 2010 Feb 18.
Department of Medical Oncology, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Pare Claret 167, 08025 Barcelona, Spain.



[Surgical resection of liver metastases from colorectal carcinoma. Experience in Sant Pau Hospital].
Cir Esp 2007 Jun;81(6):339-44
Sección de Cirugía Hepatobiliopancreática y Oncológica, Servicio de Cirugía General y Digestiva, Hospital de la Santa Creu i Sant Pau, Barcelona. España.

K-ras Asp12 mutant neither interacts with Raf, nor signals through Erk and is less tumorigenic than K-ras Val12.
Carcinogenesis 2006 Nov 5;27(11):2190-200. Epub 2006 May 5.
Grup d'Oncogènesi i Antitumorals, Institut de Recerca Hospital de la Santa Creu i Sant Pau (HSCSP), Barcelona, Spain.








Role of Kras status in patients with metastatic colorectal cancer receiving first-line chemotherapy plus bevacizumab: a TTD group cooperative study.
PLoS One 2012 12;7(10):e47345. Epub 2012 Oct 12.
Department of Medical Oncology, Hospital Clínico San Carlos (HCSC), Red Temática de Investigación Cooperativa en Cáncer, Facultad de Medicina, Universidad Complutense, Instituto de Investigación Sanitaria del HCSC (IdISSC), Madrid, Spain.

OF